Literature DB >> 9806066

Mannose-binding lectin plasma levels and gene polymorphisms in Plasmodium falciparum malaria.

A J Luty1, J F Kun, P G Kremsner.   

Abstract

The contribution of mannose-binding lectin (MBL) to protection from malaria was assessed by comparing plasma concentrations of MBL and the frequency of MBL gene polymorphisms in groups of Gabonese children participating in a prospective study of severe and mild malaria due to infection with Plasmodium falciparum. At admission, a higher proportion of patients with severe malaria had a low level of MBL compared with subjects with mild malaria (0.35 vs. 0.19, P = .02). Two mutations in codons 54 and 57 of the MBL gene were detected. They were present at higher frequency in those with severe malaria (0.45 vs. 0.31, P = .04). These results suggest that deficient innate immune responses, in the form of low MBL levels, may be a risk factor for severe malaria in some young children who lack well-developed, clinically protective acquired immune responses.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9806066     DOI: 10.1086/515690

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  37 in total

Review 1.  Immunogenetics and the design of Plasmodium falciparum vaccines for use in malaria-endemic populations.

Authors:  Magdalena Plebanski; Owen Proudfoot; Dodie Pouniotis; Ross L Coppel; Vasso Apostolopoulos; Graham Flannery
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808

2.  Tropical medicine at the University of Tübingen.

Authors:  Peter Gottfried Kremsner
Journal:  Wien Klin Wochenschr       Date:  2010-03       Impact factor: 1.704

3.  Mannan-binding lectin enhances susceptibility to visceral leishmaniasis.

Authors:  I K Santos; C H Costa; H Krieger; M F Feitosa; D Zurakowski; B Fardin; R B Gomes; D L Weiner; D A Harn; R A Ezekowitz; J E Epstein
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

4.  Toll-like receptor (TLR) polymorphisms in African children: Common TLR-4 variants predispose to severe malaria.

Authors:  Frank P Mockenhaupt; Jakob P Cramer; Lutz Hamann; Miriam S Stegemann; Jana Eckert; Na-Ri Oh; Rowland N Otchwemah; Ekkehart Dietz; Stephan Ehrhardt; Nicolas W J Schröder; Ulrich Bienzle; Ralf R Schumann
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-21       Impact factor: 11.205

5.  MBL2 variations and malaria susceptibility in Indian populations.

Authors:  Aditya Nath Jha; Pandarisamy Sundaravadivel; Vipin Kumar Singh; Sudhanshu S Pati; Pradeep K Patra; Peter G Kremsner; Thirumalaisamy P Velavan; Lalji Singh; Kumarasamy Thangaraj
Journal:  Infect Immun       Date:  2013-10-14       Impact factor: 3.441

6.  Disseminated candidiasis and hepatic malarial infection in mannose-binding-lectin-A-deficient mice.

Authors:  Sena J Lee; Gloria Gonzalez-Aseguinolaza; Michel C Nussenzweig
Journal:  Mol Cell Biol       Date:  2002-12       Impact factor: 4.272

7.  The lipopolysaccharide structures of Salmonella enterica serovar Typhimurium and Neisseria gonorrhoeae determine the attachment of human mannose-binding lectin to intact organisms.

Authors:  M Devyatyarova-Johnson; I H Rees; B D Robertson; M W Turner; N J Klein; D L Jack
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

Review 8.  How malaria has affected the human genome and what human genetics can teach us about malaria.

Authors:  Dominic P Kwiatkowski
Journal:  Am J Hum Genet       Date:  2005-07-06       Impact factor: 11.025

9.  Mannose-binding lectin is a disease modifier in clinical malaria and may function as opsonin for Plasmodium falciparum-infected erythrocytes.

Authors:  Peter Garred; Morten A Nielsen; Jørgen A L Kurtzhals; Rajneesh Malhotra; Hans O Madsen; Bamenla Q Goka; Bartholomew D Akanmori; Robert B Sim; Lars Hviid
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

10.  Parasite-host interaction in malaria: genetic clues and copy number variation.

Authors:  Imad Faik; Elisandra Grangeiro de Carvalho; Jürgen Fj Kun
Journal:  Genome Med       Date:  2009-09-02       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.